Eris Lifesciences Limited provided earnings guidance for the fiscal 2025 and fiscal 2026. For the fiscal 2025, the company are on track to meet guidance of INR 20,000 million in revenue, INR 7,000 million EBITDA and INR 4,100 million in profit after tax for the year.

For the fiscal 2026, the company has kind of a target of doing a revenue of around INR 26,000 million.